Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Liquori, C. L., Ricker, K., Moseley, M. L., Jacobsen, J. F., Kress, W., Naylor, S. L. et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293, 864–867 (2001).
Harper, P. S. in Myotonic Dystrophy (W.B. Saunders, London, 2001).
Liquori, C. L., Ikeda, Y., Weatherspoon, M., Ricker, K., Schoser, B. G., Dalton, J. C. et al. Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract. Am. J. Hum. Genet. 73, 849–862 (2003).
Day, J. W., Ricker, K., Jacobsen, J. F., Rasmussen, L. J., Dick, K. A., Kress, W. et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60, 657–664 (2003).
Bachinski, L. L., Udd, B., Meola, G., Sansone, V., Bassez, G., Eymard, B. et al. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Am. J. Hum. Genet. 73, 835–848 (2003).
Udd, B., Meola, G., Krahe, R., Thornton, C., Ranum, L., Day, J. et al. Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies: 3rd Workshop. Neuromuscul. Disord. 13, 589–596 (2003).
Coenen, M. J., Tieleman, A. A., Schijvenaars, M. M., Leferink, M., Ranum, L. P., Scheffer, H. et al. Dutch myotonic dystrophy type 2 patients and a North-African DM2 family carry the common European founder haplotype. Eur. J. Hum. Genet. 19, 567–570 (2011).
Saito, T., Amakusa, Y., Kimura, T., Yahara, O., Aizawa, H., Ikeda, Y. et al. Myotonic dystrophy type 2 in Japan: ancestral origin distinct from Caucasian families. Neurogenetics 9, 61–63 (2008).
Young, N. P., Daube, J. R., Sorenson, E. J. & Milone, M. Absent, unrecognized, and minimal myotonic discharges in myotonic dystrophy type 2. Muscle Nerve 41, 758–762 (2010).
Suominen, T., Bachinski, L. L., Auvinen, S., Hackman, P., Baggerly, K. A., Angelini, C. et al. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur. J. Hum. Genet. 19, 776–782 (2011).
Acknowledgements
We appreciate the cooperation of all patients and doctors who participated in this investigation. This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, as well as Research Grants for Intractable Diseases from the Ministry of Health, Labour and Welfare, Japan (TM, KO, KA, YKH, IN).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Matsuura, T., Minami, N., Arahata, H. et al. Myotonic dystrophy type 2 is rare in the Japanese population. J Hum Genet 57, 219–220 (2012). https://doi.org/10.1038/jhg.2011.152
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2011.152
This article is cited by
-
Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects
Neurological Sciences (2017)
-
Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach
Journal of Neurology (2017)
-
Clinical and genetic analysis of the first known Asian family with myotonic dystrophy type 2
Journal of Human Genetics (2014)
-
Recent Advances in Myotonic Dystrophy Type 2
Current Neurology and Neuroscience Reports (2014)